ATE392150T1 - Verfahren und formulierungen, die sich für die reduktion des cholesteringehalts von eigelb eignen - Google Patents

Verfahren und formulierungen, die sich für die reduktion des cholesteringehalts von eigelb eignen

Info

Publication number
ATE392150T1
ATE392150T1 AT03795587T AT03795587T ATE392150T1 AT E392150 T1 ATE392150 T1 AT E392150T1 AT 03795587 T AT03795587 T AT 03795587T AT 03795587 T AT03795587 T AT 03795587T AT E392150 T1 ATE392150 T1 AT E392150T1
Authority
AT
Austria
Prior art keywords
reducing
methods
formulations suitable
cholesterol content
egg yolks
Prior art date
Application number
AT03795587T
Other languages
English (en)
Inventor
Curtis A Spilburg
Original Assignee
Zomanex Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zomanex Llc filed Critical Zomanex Llc
Application granted granted Critical
Publication of ATE392150T1 publication Critical patent/ATE392150T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/70—Feeding-stuffs specially adapted for particular animals for birds
    • A23K50/75—Feeding-stuffs specially adapted for particular animals for birds for poultry
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/105—Aliphatic or alicyclic compounds

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Birds (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Fodder In General (AREA)
  • Feed For Specific Animals (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
AT03795587T 2002-09-10 2003-08-06 Verfahren und formulierungen, die sich für die reduktion des cholesteringehalts von eigelb eignen ATE392150T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US40946902P 2002-09-10 2002-09-10

Publications (1)

Publication Number Publication Date
ATE392150T1 true ATE392150T1 (de) 2008-05-15

Family

ID=31993971

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03795587T ATE392150T1 (de) 2002-09-10 2003-08-06 Verfahren und formulierungen, die sich für die reduktion des cholesteringehalts von eigelb eignen

Country Status (7)

Country Link
US (1) US20040047946A1 (de)
EP (1) EP1536693B1 (de)
AT (1) ATE392150T1 (de)
AU (1) AU2003257189A1 (de)
CA (1) CA2488653C (de)
DE (1) DE60320422D1 (de)
WO (1) WO2004023888A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004055858A1 (de) * 2004-11-19 2006-05-24 Clariant Gmbh Verwendung von langkettigen Alkoholen zur effektiven Senkung erhöhter Cholesterinspiegel
FR2950061B1 (fr) 2009-09-11 2013-12-20 Coatex Sas Monomeres associatifs a base de polycosanols, epaississants associatifs correspondants et leurs utilisations
JP7257651B2 (ja) * 2017-12-26 2023-04-14 Ｊａ東日本くみあい飼料株式会社 養鶏用飼料の製造方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5091195A (en) * 1989-07-24 1992-02-25 Havens Alice L System for producing low cholesterol eggs and feed additive resulting in same
EP0543417A1 (de) * 1991-11-22 1993-05-26 Lipogenics, Incorporated Tocotrienole und Focotrienol-ähnliche Verbindungen und Verfahren zu ihrer Verwendung
JP3124409B2 (ja) * 1993-03-24 2001-01-15 松谷化学工業株式会社 鶏飼料
US5932562A (en) * 1998-05-26 1999-08-03 Washington University Sitostanol formulation to reduce cholesterol absorption and method for preparing and use of same
DE19835850A1 (de) * 1998-08-07 2000-02-10 Basf Ag Verwendung von Hemmstoffen der HMG-CoA-Reduktase zur Senkung des Cholesteringehaltes in Geflügelei
US6436451B1 (en) * 1999-03-26 2002-08-20 Eggland's Best, Inc. Method of reducing cholesterol in chicken eggs
US6225354B1 (en) * 1999-06-21 2001-05-01 Cholesterol Control Laboratories, Inc. High molecular weight primary aliphatic alcohols obtained from beeswax and pharmaceutical use thereof
FI4199U1 (fi) * 1999-07-07 1999-10-28 Suomen Rehu Oy Elintarvike ja rehu
US6197832B1 (en) * 1999-09-14 2001-03-06 Harlan Lee Sorkin, Jr. Composition for reducing serum cholesterol levels
US6316041B1 (en) * 1999-10-26 2001-11-13 Liferight Foods, L.L.C. Poultry egg with beneficial health and nutritive values

Also Published As

Publication number Publication date
EP1536693B1 (de) 2008-04-16
CA2488653C (en) 2008-10-07
US20040047946A1 (en) 2004-03-11
AU2003257189A1 (en) 2004-04-30
EP1536693A1 (de) 2005-06-08
DE60320422D1 (de) 2008-05-29
CA2488653A1 (en) 2004-03-25
WO2004023888A1 (en) 2004-03-25

Similar Documents

Publication Publication Date Title
CY1113306T1 (el) Παραγωγα της κινολινης και η χρηση τους ως προσδεματων 5-ht6
DE602004024572D1 (de) Zusammensetzungen, die sich als inhibitoren von proteinkinasen eignen
ATE526991T1 (de) Zusammensetzungen und ihre verwendungen für die gentherapeutische behandlung von knochenerkrankungen
ATE433973T1 (de) Azolylaminoazine als inhibitoren von proteinkinasen
PL356846A1 (en) Use of interleukin-6 antagonists for the treatment of diseases characterised by high levels of aromatase
EA200700175A1 (ru) Композиции и способы лечения воспалительных заболеваний
DE602004014117D1 (de) Thiazole zur verwendung als inhibitoren von protein-kinasen
GEP20074078B (en) Fluoro substituted cyclo-alkanoindoles, compositions comprising them and their use
IL181629A0 (en) Compositions and methods for the diagnosis and tretment of tumor
DE60035232D1 (de) (S,S)-Reboxetine zur Behandlung von chronischen Erschöpfungssyndrom
NO20041917D0 (no) Spesifikke midler som binder humant angiopoietin-2
MA28985B1 (fr) Analogues de loxapine et methodes d'utilisation
DE60021381D1 (de) Chinonverbindungen zur behandlung von krankheiten
DE602004012578D1 (de) Als inhibitoren von c-met geeignete pyrrolzusammensetzungen
NO20050091L (no) Fremgangsmater for fremstilling av fibrinogen
NO20055741L (no) Nye kjemiske forbindelser
ATE549024T1 (de) Chinazolin-kaliumkanalhemmer
MXPA05009743A (es) Composiciones con actividad hematopoyetica e inmune.
ATE476419T1 (de) Isochinolinon-kaliumkanalinhibitoren
NO20065859L (no) Bruk av IL-17 behandlingen av fertilitetsrelaterte lidelser
MXPA05011699A (es) Inhibidores de la bomba de protones para el tratamiento de trastornos del abdomen inferior.
DE602004019541D1 (de) Cycloalkyläbü kondensierte indole
DE60320422D1 (de) Verfahren und formulierungen, die sich für die reduktion des cholesteringehalts von eigelb eignen
ATE420162T1 (de) Verfahren und zusammensetzungen zum targeting sekretorischer lysosomen
ATE536874T1 (de) Dreifache monoamin-wiederaufnahmehemmer zur behandlung von chronischen schmerzen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties